The short version of HGF/c-Met fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-07-17 and is reviewed periodically as new material appears.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Marketed for research use in some regions. |
| Human clinical data | Limited or absent | Most evidence is from cell and animal studies. |
| Primary proposed pathway | HGF/c-Met signaling | Angiotensin IV-related activity also reported. |
| Common study models | Rodent neurons and behavioral tasks | Results may not translate directly to humans. |
| Key uncertainty | Bioavailability and brain exposure | Questions remain about absorption and target engagement. |
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
Administration: Administers the Secretariat as well as looks after personal matters of the Chairman/Members and other Officers/Staff of the commission. All India Services: Recruitment to All India Services is done either by direct recruitment, through Civil Services Examination or by promotion from the State Service. The AIS Branch handles the promotions of State Service officers to the IAS, IPS and IFS. It also handles policy matters relating to All India Services and amendments in the 'Promotion Regulations' of respective services. Appointments: It carries out appointments to central services based on Promotion (based on proposals from various Ministries/Departments/Union Territories and from certain local bodies) and by the means of Deputation and Absorption. Examinations: It carries out merit-based selection and recommendation of candidates through various examinations such as the Engineering Services Examination, Combined Medical Services Examination, Defence Services Examination, Civil Services Examination, etc., to Group A and Group B Services of the Government of India. General: Primarily deals with day-to-day housekeeping work for the Commission, such as arrangements and facilitation for the conduct of Examinations by the UPSC, printing the Annual Report, etc.
== Literature == Schaefer, T. (1962). "The Proton Magnetic Resonance Spectrum of 1-Fluoro-2,4-Dinitrobenzene". Canadian Journal of Chemistry. 40 (3): 431–433. doi:10.1139/v62-068. Nageswara Rao, B.D. (1964). "The1H and19F resonance spectra of 1-fluoro-2,4-dinitrobenzene". Molecular Physics. 7 (4): 307–310. Bibcode:1964MolPh...7..307N. doi:10.1080/00268976300101071. Wilkins, A.; Small, R. W. H. (1991). "Structure of 1-fluoro-2,4-dinitrobenzene". Acta Crystallographica Section C. 47 (1): 220–221. Bibcode:1991AcCrC..47..220W. doi:10.1107/S0108270190007326.
== Active site and mechanism of catalysis == The active site of eqolosin contains a distinctive glutamic acid and glutamine catalytic dyad which are involved in substrate binding and catalysis. These residues act as a nucleophile, with the glutamic acid serving as a general acid in the first phase of the reaction, donating a proton to the carbonyl oxygen in the peptide bond of the substrate. One or two water molecules may be involved in the reaction supplying a hydroxyl group, and the glutamic acid further donates a proton to the amide nitrogen, resulting in breakage of the peptide bond. The glutamine then returns the glutamic acid to its initial state.
Sources: en.wikipedia.org
Jessie McTavish, a nurse convicted and then controversially cleared of the 1974 murder of an 80-year-old patient with insulin, has been identified as the likely inspiration for Norris. She had worked at Ruchill Hospital in Glasgow, less than a mile from where Norris grew up. She had been released on appeal after her defence team successfully argued that the trial judge had inadvertently misled the jury in his final summing up, even though the appeal court judges said that it was something a "few words could have cured" and that there was enough evidence to support the prosecution. Norris's personal tutor at university gave a specific talk to him and other students on her case on 11 January 2001, a year before Norris committed his first attack, in which Norris used the same method as McTavish had been accused of using. Norris was tasked with "reviewing" her conduct, and in doing so, he would have learned that insulin is the perfect weapon for murder because it leaves the blood very quickly. Just like Norris, McTavish had 'predicted' the exact time when a healthy patient would die. She was able to continue her career in nursing after she was released on appeal. Norris had notably also attended lectures in 1999 on diabetes and the treatment of diabetic patients with insulin, where he learned about the consequences of blood sugars being too high or too low.
The American tea culture is a part of the history of the United States, as tea has appealed to all classes and has adapted to the customs of the United States. The Native peoples of North America drank various herbal teas, the most common of which was Yaupon tea, known as the "Beloved drink", "Cassina", or "White drink". It was brewed from yaupon holly (Ilex vomitoria), which is native to the Atlantic and Gulf Coasts. Native American tribes like the Chickasaw, Cherokee, Choctaw, Muscogee, and Timucua used the tea as a daily drink, as a social drink used in meetings, and in various rituals, many of which were associated with purification. Yaupon tea was adopted by European colonists as early as the 17th century who gave it various names like "Black drink", "Carolina Tea", "South Seas Tea", or "Indian tea".
=== Souvenirs and general merchandise === Besides food and drinks, the company offers a variety of general and regional-based souvenirs, including apparel and artwork featuring their logo and mascot. The chain carries its own clothing brand, ranging from t-shirts to hats, beanies, pants, plushies, swimwear, and blankets. Stores also carry general kitchen goods: cast iron skillets, food containers, mugs, glassware, cookbooks, coolers, and vacuum flasks, among other items. General travel products are sold along with phone accessories. Various locations sell hunting gear and equipment alongside outdoor products like grills and fire pits.
== SW == sw – (s) Swahili language (ISO 639-1 code) SW (s) South-West ordinal direction Sweden (FIPS 10-4 country code) (a) Shortwave Star Wars swa – (s) Swahili language (ISO 639-2 code) SWA (i/a) Secure Web Access South-West Asia SWAC – (p) Southwestern Athletic Conference SWAG Scientific wild-ass guess, slang for a rough estimate based on expert experience Sourceware Archive Group, a free collection of classified source code and sample programs written in Pascal Sport Writers Association of Ghana, Sports Writers Association based in Ghana Special Warfare Group, a former name used by the Naval Special Operations Command "Supporters Without A Game", sport slang spun off from WAGs ("wives and girlfriends") SWALK – (a) Sealed With A Loving Kiss SWAN – (a) System for Wearable Audio Navigation SWAP – (a) Surface Waters Acidification Programme SWAPO – (a) South-West Africa People's Organisation SWAT – (a) Special Weapons And Tactics swe – (s) Swedish language (ISO 639-2 code) SWE – (s) Sweden (ISO 3166 trigram) SWF (p) Shockwave Flash file ("swiff") Single White Female SWG (i) Surface Warfare Group Symbology Working Group SWHR – (i) Society for Women's Health Research SWIG – (a) Simplified Wrapper and Interface Generator SWIR – (a/i) Short Wave InfraRed ("ss-why-are" or "swhirr") SWLABR – (i) "She Was Like A Bearded Rainbow", a song by the band Cream SWORD – (p) Subjective WORkload Dominance SWORDS – (a) Special Weapons Observation Reconnaissance Detection System SWOT – (a) Strengths, Weaknesses, Opportunities, Threats (mnemonic) SWP (i) Special Working Party ("swipp") Systematic Westing Plan (a plan of periodic westing of shares or mutual funds worth a fixed amount of money) Skill with prize (UK pub quiz machines — quality titles include: Pub Quiz, Quiz City, Frog in a Liquidizer, Who Wants To Win a Tenner?) SWT – (i) Sea Water Tank SWV – (i) Sisters With Voices (American female R&B vocal group) SWZ – (s) Swaziland (ISO 3166 trigram)
Sources: en.wikipedia.org
On 2 March, Hezbollah fired several rockets at northern Israel, setting off sirens in Haifa and the Upper Galilee. The group said its actions were in response to the assassination of Iranian supreme leader Ali Khamenei. One of the rockets was intercepted, while several others hit open areas. Hezbollah later claimed that the attack was a "defensive act" after over a year of Israeli attacks despite a truce. It added that it restarted fighting to force Israel to stop its aggression and evacuate from seized Lebanese territories, emphasising that the move was unrelated to the Iran war. The IAF and Israeli Navy conducted extensive retaliatory strikes across Lebanon, mainly targeting Dahieh and southern Lebanon. The IDF said it struck over 70 targets, while issuing evacuation orders for over 50 villages in the south and east. It added that Hussein Meklad, Hezbollah's intelligence chief, was killed. At least 52 people were killed, 154 were injured, and 29,000 others were displaced, according to the Lebanese Health Ministry. In response to Hezbollah's actions, prime minister Nawaf Salam banned the group from conducting military activities. On 3 March, Israel resumed ground operations in Lebanon and continued conducting strikes. Attacks hit weapons facilities, command centers, and communication equipment, along with the studios of Hezbollah-linked outlets Al-Nour and Al-Manar. The IDF said it struck 160 targets since the escalation and announced that it killed a senior liaison to the IRGC in Beirut the day prior.
Authorities in Italy have investigated a 'Ndrangheta mafia clan accused of trafficking and illegally dumping nuclear waste. According to a whistleblower, a manager of the Italy state energy research agency Enea paid the clan to get rid of 600 drums of toxic and radioactive waste from Italy, Switzerland, France, Germany, and the United States, with Somalia as the destination, where the waste was buried after buying off local politicians. Former employees of Enea are suspected of paying the criminals to take waste off their hands in the 1980s and 1990s. Shipments to Somalia continued into the 1990s, while the 'Ndrangheta clan also blew up shiploads of waste, including radioactive hospital waste, sending them to the sea bed off the Calabrian coast. According to the environmental group Legambiente, former members of the 'Ndrangheta have said that they were paid to sink ships with radioactive material for the last 20 years. In 2008, Afghan authorities accused Pakistan of illegally dumping nuclear waste in the southern parts of Afghanistan when the Taliban were in power between 1996 and 2001. The Pakistani government denied the allegation.
Intranasal midazolam is found to be highly effective in acute episodes of seizures in children. Recently, the upper part of the nasal cavity, as high as the cribriform plate, has been proposed for drug delivery to the brain. This "transcribrial route", published first in 2014, was suggested by the author for drugs to be given for Primary Meningoencephalitis.
This government, commanding a two-thirds supermajority in the Volkskammer, set about the task of dismantling the East German state and laying the legal groundwork for reunification, although the coalition would collapse later that August. On 3 October 1990, the GDR ceased to exist and all its territories joined the Federal Republic of Germany (FRG). 144 Volkskammer members were integrated into the West German Bundestag, serving until the all-German federal election on 2 December that year.
=== Nomenclature === The German chemist Wilhelm Körner suggested the prefixes ortho-, meta-, para- to distinguish di-substituted benzene derivatives in 1867; however, he did not use the prefixes to distinguish the relative positions of the substituents on a benzene ring. It was the German chemist Carl Gräbe who, in 1869, first used the prefixes ortho-, meta-, para- to denote specific relative locations of the substituents on a di-substituted aromatic ring (viz, naphthalene). In 1870, the German chemist Viktor Meyer first applied Gräbe's nomenclature to benzene.
Sources: en.wikipedia.org
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.
Preclinical research has focused on synaptic growth, cognitive performance in animals, and HGF/c-Met signaling. These are experimental findings, not established treatments.
Legality varies by country and intended use. It is commonly sold as a research chemical, and sales for human consumption may be restricted. Local regulations should be checked.
Dry powder is usually kept frozen, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data for dihexa are limited, so general peptide storage practices are commonly used.